Dissection of cellular and molecular mechanisms of aristolochic acid-induced hepatotoxicity via single-cell transcriptomics.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac023
- By:
- Publication type:
- Article
Works matching IS 20965303 AND DT 2022 AND VI 5 AND IP 4
Results: 8
1
2
Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac030
- By:
- Publication type:
- Article
3
Aztreonam-avibactam: an option against carbapenem-resistant Enterobacterales with emerging resistance.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac029
- By:
- Publication type:
- Article
4
Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac028
- By:
- Publication type:
- Article
5
Precision prevention of monkeypox.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac026
- By:
- Publication type:
- Article
6
Correction to: Blockade of integrin signaling reduces chemotherapy-induced premature senescence in collagen cultured bladder cancer cells.
- Published in:
- 2022
- Publication type:
- Correction Notice
7
Recent advances in small-molecular therapeutics for COVID-19.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac024
- By:
- Publication type:
- Article
8
Precision medicine in cardiorenal and metabolic diseases with routinely collected clinical data: a novel insight.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 4, p. 1, doi. 10.1093/pcmedi/pbac025
- By:
- Publication type:
- Article